Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion recall
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Clarithromycin 500 mg powder for concentrate for solution for infusion.
Published: 11 December 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Clarithromycin 500 mg powder for concentrate for solution for infusion. Hameln Pharma Ltd is recalling specified batches of Clarithromycin 500 mg powder for concentrate for solution for infusion.
Following an inspection of the clarithromycin lactobionate raw material manufacturer, the certification of suitability for use in medicines was withdrawn due to non-compliance with Good Manufacturing Practice.
Further information, advice and details of the affected batches can be found on the MHRA website.